The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells

Oncogene

Volumn 23, Issue 6, 2004, Pages 1263-1274

  Regl, Gerhard ^a   Kasper, Maria ^a   Schnidar, Harald ^a   Eichberger, Thomas ^a   Neill, Graham W ^b   Ikram, Mohammed S ^b   Quinn, Anthony G ^c   Philpott, Mike P ^b   Frischauf, Anna Maria ^a   Aberger, Fritz ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Basal cell carcinoma; Cell cycle; Epidermal differentiation; GLI proteins; Hedgehog signalling; Keratinocytes

Indexed keywords

CELL CYCLE PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR GLI2; UNCLASSIFIED DRUG; GLI2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; NUCLEAR PROTEIN; PRIMER DNA; ZINC FINGER PROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; EPIDERMIS; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; MITOSIS INHIBITION; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN TUMOR; UNINDEXED SEQUENCE; ZINC FINGER MOTIF; CELL CYCLE; CELL LINE; CELL TRANSFORMATION; CONTACT INHIBITION; CYTOLOGY; DRUG EFFECT; GENETICS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ERINACEIDAE;

BASE SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CONTACT INHIBITION; DNA PRIMERS; EPIDERMIS; HUMANS; KERATINOCYTES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; ZINC FINGERS;

EID: 1442303112     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207240     Document Type: Article

References (60)

1. Aberger F, Costa-Pereira AP, Schlaak JF, Williams TM, O'Shaughnessy RF, Hollaus G, Kerr IM and Frischauf AM. (2001). Genomics, 77, 50-57.
2. Arata Y, Fujita M, Ohtani K, Kijima S and Kato JY. (2000). J. Biol. Chem., 275, 6337-6345.
3. Aza-Blanc P, Ramirez-Weber FA, Laget MP, Schwartz C and Kornberg TB. (1997). Cell, 89, 1043-1053.
4. Bai CB, Auerbach W, Lee JS, Stephen D and Joyner AL. (2002). Development, 129, 4753-4761.
5. Bikle DD, Ng D, Tu CL, Oda Y and Xie Z. (2001). Mol. Cell. Endocrinol., 177, 161-171.
6. Bonifas JM, Pennypacker S, Chuang PT, McMahon AP, Williams M, Rosenthal A, De Sauvage FJ and Epstein Jr EH. (2001). J. Invest. Dermatol., 116, 739-742.
7. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A and Fusenig NE. (1988). J. Cell Biol., 106, 761-771.
8. Chopra A, Maitra B and Korman NJ. (1998). J. Invest. Dermatol., 110, 52-56.
9. Deng H, Lin Q and Khavari PA. (1997). Nat. Biotechnol., 15, 1388-1391.
10. Ding Q, Motoyama J, Gasca S, Mo R, Sasaki H, Rossant J and Hui CC. (1998). Development, 125, 2533-2543.
11. Duman-Scheel M, Weng L, Xin S and Du W. (2002). Nature, 417, 299-304.
12. Fan H and Khavari PA. (1999). J. Cell Biol., 147, 71-76.
13. Garach-Jehoshua O, Ravid A, Liberman UA, Reichrath J, Glaser T and Koren R. (1998). Br. J. Dermatol., 139, 950-957.
14. Goodrich LV and Scott MP. (1998). Neuron, 21, 1243-1257.
15. Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, Hui CC and Dlugosz AA. (2000). Nat. Genet., 24, 216-217.
16. Harbour JW and Dean DC. (2000). Genes Dev., 14, 2393-2409.
17. Helin K. (1998). Curr. Opin. Genet. Dev., 8, 28-35.
18. Ingham PW and McMahon AP. (2001). Genes Dev., 15, 3059-3087.
19. Jee SH, Shen SC, Chiu HC, Tsai WL and Kuo ML. (2001). Oncogene, 20, 198-208.
20. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein Jr EH and Scott MP. (1996). Science, 272, 1668-1671.
21. Jones PH, Harper S and Watt FM. (1995). Cell, 80, 83-93.
22. Kenney AM and Rowitch DH. (2000). Mol. Cell. Biol., 20, 9055-9067.
23. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N and Rogan EM et al. (1993). Carcinogenesis, 14, 833-839.
24. Martin KJ, Graner E, Li Y, Price LM, Kritzman BM, Fournier MV, Rhei E and Pardee AB. (2001). Proc. Natl. Acad. Sci. USA, 98, 2646-2651.
25. Matise MP, Epstein DJ, Park HL, Platt KA and Joyner AL. (1998). Development, 125, 2759-2770.
26. Medvedev A, Saunders NA, Matsuura H, Chistokhina A and Jetten AM. (1999). J. Biol. Chem., 274, 3887-3896.
27. Mill P, Mo R, Fu H, Grachtchouk M, Kim PC, Dlugosz AA and Hui CC. (2003). Genes Dev., 17, 282-294.
28. Morasso MI, Markova NG and Sargent TD. (1996). J. Cell Biol., 135, 1879-1887.
29. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD and Helin K. (2001). Genes Dev., 15, 267-285.
30. Mullor JL, Sanchez P and Altaba AR. (2002). Trends Cell Biol., 12, 562-569.
31. Nickoloff BJ, Qin JZ, Chaturvedi V, Denning MF, Bonish B and Miele L. (2002). Cell Death Differ., 9, 842-855.
32. Nilsson M, Unden AB, Krause D, Malmqwist U, Raza K, Zaphiropoulos PG and Toftgard R. (2000). Proc. Natl. Acad. Sci. USA, 97, 3438-3443.
33. Ohtani K, DeGregori J and Nevins JR. (1995). Proc. Natl. Acad. Sci. USA, 92, 12146-12150.
34. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein Jr EH and Scott MP. (1997). Science, 276, 817-821.
35. Park HL, Bai C, Platt KA, Matise MP, Beeghly A, Hui CC, Nakashima M and Joyner AL. (2000). Development, 127, 1593-1605.
36. Regl G, Neill GW, Eichberger T, Kasper M, Ikram MS, Koller J, Hintner H, Quinn AG, Frischauf AM and Aberger F. (2002). Oncogene, 21, 5529-5539.
37. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA and Dynlacht BD. (2002). Genes Dev., 16, 245-256.
38. Rheinwald JG and Green H. (1975). Cell, 6, 331-343.
39. Rutberg SE, Saez E, Glick A, Dlugosz AA, Spiegelman BM and Yuspa SH. (1996). Oncogene, 13, 167-176.
40. Sasaki H, Nishizaki Y, Hui C, Nakafuku M and Kondoh H. (1999). Development, 126, 3915-3924.
41. Savoia P, Trusolino L, Pepino E, Cremona O and Marchisio PC. (1993). J. Invest. Dermatol., 101, 352-358.
42. Schoop VM, Mirancea N and Fusenig NE. (1999). J. Invest. Dermatol., 112, 343-353.
43. Sheng H, Goich S, Wang A, Grachtchouk M, Lowe L, Mo R, Lin K, de Sauvage FJ, Sasaki H, Hui CC and Dlugosz AA. (2002). Cancer Res., 62, 5308-5316.
44. Sherr CJ. (2000). Cancer Res., 60, 3689-3695.
45. Steinert PM and Marekov LN. (1995). J. Biol. Chem., 270, 17702-17711.
46. Stone DM, Hynes M, Armanini M, Swanson TA, Gu Q, Johnson RL, Scott MP, Pennica D, Goddard A, Phillips H, Noll M, Hooper JE, de Sauvage F and Rosenthal A. (1996). Nature, 384, 129-134.
47. Takahashi H, Kinouchi M, Wuepper KD and Iizuka H. (1997). J. Invest. Dermatol., 108, 843-847.
48. Toftgard R. (2000). Cell. Mol. Life Sci., 57, 1720-1731.
49. Tuominen H, Pollanen R and Kallioinen M. (1997). J. Cutan. Pathol., 24, 590-596.
50. Tusher VG, Tibshirani R and Chu G. (2001). Proc. Natl. Acad. Sci. USA, 98, 5116-5121.
51. Varani J, Hattori Y, Chi Y, Schmidt T, Perone P, Zeigler ME, Fader DJ and Johnson TM. (2000). Br. J. Cancer, 82, 657-665.
52. Watanabe R, Wu K, Paul P, Marks DL, Kobayashi T, Pittelkow MR and Pagano RE. (1998). J. Biol. Chem., 273, 9651-9655.
53. Weiner HL, Bakst R, Hurlbert MS, Ruggiero J, Ahn E, Lee WS, Stephen D, Zagzag D, Joyner AL and Turnbull DH. (2002). Cancer Res., 62, 6385-6389.
54. Welter JF, Crish JF, Agarwal C and Eckert RL. (1995). J. Biol. Chem., 270, 12614-12622.
55. Werner S and Smola H. (2001). Trends Cell Biol., 11, 143-146.
56. Wetmore C. (2003). Curr. Opin. Genet. Dev., 13, 34-42.
57. Xie J, Aszterbaum M, Zhang X, Bonifas JM, Zachary C, Epstein E and McCormick F. (2001). Proc. Natl. Acad. Sci. USA, 98, 9255-9259.
58. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, Rosenthal A, Epstein Jr EH and de Sauvage FJ. (1998). Nature, 391, 90-92.
59. Yoon JW, Kita Y, Frank DJ, Majewski RR, Konicek BA, Nobrega MA, Jacob H, Walterhouse D and Iannaccone P. (2002). J. Biol. Chem., 277, 5548-5555.
60. Zettergren JG, Peterson LL and Wuepper KD. (1984). Proc. Natl. Acad. Sci. USA, 81, 238-242.